Related references
Note: Only part of the references are listed.Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
Joseph N. Brewoo et al.
VACCINE (2012)
Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
Jorge E. Osorio et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
Jorge E. Osorio et al.
VACCINE (2011)
Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines
O'Neil Wiggan et al.
VACCINE (2011)
Replication of the Primary Dog Kidney-53 Dengue 2 Virus Vaccine Candidate in Aedes aegypti Is Modulated by a Mutation in the 5′ Untranslated Region and Amino Acid Substitutions in Nonstructural Proteins 1 and 3
Aaron C. Brault et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2011)
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B. Halstead et al.
LANCET INFECTIOUS DISEASES (2010)
Dengue: a continuing global threat
Maria G. Guzman et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Dengue virus - Mosquito interactions
Scott B. Halstead
ANNUAL REVIEW OF ENTOMOLOGY (2008)
Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA
S Butrapet et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus
CYH Huang et al.
JOURNAL OF VIROLOGY (2005)
Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: Infant mice provide an accurate surrogate for the test in monkeys
TP Monath et al.
BIOLOGICALS (2005)
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development
CYH Huang et al.
JOURNAL OF VIROLOGY (2003)
Growth characteristics of ChimeriVaxTM-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes
BW Johnson et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Live attenuated tetravalent dengue vaccine
N Bhamarapravati et al.
VACCINE (2000)
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′ noncoding region and nonstructural proteins 1 and 3
S Butrapet et al.
JOURNAL OF VIROLOGY (2000)
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine
CYH Huang et al.
JOURNAL OF VIROLOGY (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
